ID   GENEA019
AC   CVCL_9028
SY   Genea019; GENEA-019; SIVF019; SIV019; GENEAe020-A
DR   BioSamples; SAMEA104013010
DR   hPSCreg; GENEAe020-A
DR   ISCR; 1181
DR   SKIP; SKIP002919
DR   Wikidata; Q54835581
RX   PubMed=20649476;
RX   PubMed=25316320;
RX   PubMed=27217344;
RX   PubMed=27346002;
RX   PubMed=35805069;
WW   https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
WW   https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-62.
CC   Omics: Array-based CGH.
CC   Omics: Proteome analysis.
CC   Donor information: Embryo is sibling to that giving rise to GENEA020 (Cellosaurus=CVCL_9029).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346002
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 12,18
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 18,23
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 7,8
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   TH01: 9.3,10
ST   TPOX: 11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 18
//
RX   PubMed=20649476; DOI=10.1089/scd.2010.0120;
RA   Bradley C.K., Scott H.A., Chami O., Peura T.T., Dumevska B.,
RA   Schmidt U., Stojanov T.;
RT   "Derivation of Huntington's disease-affected human embryonic stem cell
RT   lines.";
RL   Stem Cells Dev. 20:495-502(2011).
//
RX   PubMed=25316320; DOI=10.1021/pr500649m;
RA   McQuade L.R., Balachandran A., Scott H.A., Khaira S., Baker M.S.,
RA   Schmidt U.;
RT   "Proteomics of Huntington's disease-affected human embryonic stem
RT   cells reveals an evolving pathology involving mitochondrial
RT   dysfunction and metabolic disturbances.";
RL   J. Proteome Res. 13:5648-5659(2014).
//
RX   PubMed=27217344; DOI=10.5966/sctm.2015-0224;
RA   Caron L., Kher D., Lee K.L., McKernan R., Dumevska B., Hidalgo A.,
RA   Li J., Yang H., Main H., Ferri G., Petek L.M., Poellinger L.,
RA   Miller D.G., Gabellini D., Schmidt U.;
RT   "A human pluripotent stem cell model of facioscapulohumeral muscular
RT   dystrophy-affected skeletal muscles.";
RL   Stem Cells Transl. Med. 5:1145-1161(2016).
//
RX   PubMed=27346002; DOI=10.1016/j.scr.2016.02.008;
RA   Dumevska B., Peura T.T., McKernan R., Goel D., Schmidt U.;
RT   "Derivation of human embryonic stem cell line Genea019.";
RL   Stem Cell Res. 16:397-400(2016).
//
RX   PubMed=35805069; DOI=10.3390/cells11131984;
RA   Molina-Ruiz F.J., Introna C., Bombau G., Galofre M., Canals J.M.;
RT   "Standardization of cell culture conditions and routine genomic
RT   screening under a quality management system leads to reduced genomic
RT   instability in hPSCs.";
RL   Cells 11:1984.1-1984.25(2022).
//